Deciphera Pharmaceuticals (DCPH) ROE US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -35.0% | -49.0% | -97.4% | -52.4% | -55.6% | -60.2% | ||
| Changes by years, y/y, % | +1pp | -14pp | -48pp | +45pp | -3pp | +9.3% | |||
Deciphera Pharmaceuticals. ROE, %
Deciphera Pharmaceuticals. ROE, changes, pp
Deciphera Pharmaceuticals (DCPH) ROE US GAAP (quarter values) |
||||||||
| FY2023Q1 | FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | LTM ? | |||
| ROE, % | ? | -40.1% | -45.4% | -50.7% | -55.6% | -60.2% | -60.2% | |
| Changes by years, y/y, % | +65pp | +18pp | +7pp | -5pp | -20pp | |||
| Changes by quarters, q/q, % | +11pp | -5pp | -5pp | -5pp | -5pp | |||